Alave Rosas, Jorge Luis

Cargando...
Miniatura
Nombre preferido
Alave Rosas, Jorge Luis
Afiliación principal
Correo electrónico
jorgealave@upeu.edu.pe
ORCID
ID de autor de Scopus

Ajustes

Mostrando 1 - 10 de 61
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
    1291. Acceptability and Perceptions towards an International Infectious Disease Videoconferencing Program among medical students and physicians-in-training in Miami.
    (2022-12-01)
    Anmary Fernandez
    ;
    Daniela De Lima
    ;
    Paola Lichtenberger
    ;
    Jorge Alave  
    ;
    Sebastián Solar
    Abstract Background Tele-education has emerged as an excellent alternative for traditional face-to-face education. It has allowed to connect first-world countries to developing countries for learning about low prevalent pathologies, such as tropical diseases, parasite infections, etc. Methods The Division of Infectious Diseases at University of Miami started an international videoconferencing program in 2018 in collaboration with 4 teaching sites (Miami, Peru, Chile, and Spain), in which 2 challenging cases were presented via Skype TM or Zoom TM. The cases were discussed by a partner institution member; all sites were invited to comment about the cases. After each conference, the medical students and physicians-in-training were asked to fill out a survey to evaluate their acceptance and perceptions towards this program. Results 54 participants completed the survey. 50% were residents or fellows, 18.5% were medical students, and 27.7% were visiting trainees. The overall acceptance was favorable, 64.9 % of participants reported that videoconferencing was as effective or more effective than face-to-face conferences, 96.3% wanted to continue participating in this program, and 87.04% would recommend it as an educational tool. Regarding the collaboration with international sites, 87% of participants felt they learned about diseases not commonly encountered in their countries, 85.2% considered that this program allowed them to learn about different treatment approaches, and 68.5% believed that it helped to learn about novel diagnostic tests. In terms of the content, 85.2% considered that the cases were interesting and 83.3 % believed that the cases were presented in an organized fashion. Regarding the software performance, 75.9 % believed that images were above average or outstanding, but only 48.1% felt the same about the audio. In terms of participation, 57.4% believed that interaction between the local audience and physicians from different sites was easily accomplished. Conclusion This videoconferencing program was widely accepted among trainees. The collaboration with international sites was perceived as one of the program assets. We believe that implementation of programs like this would be highly beneficial in Infectious Disease education. Disclosures Daniela De Lima, MD, Astra Zeneca: Stocks/Bonds|Pfizer: Stocks/Bonds.
    Citas (OpenAlex): 1
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
    Level of Knowledge Regarding Mpox among Peruvian Physicians during the 2022 Outbreak: A Cross-Sectional Study
    (2023-01-12)
    Jose Armando Gonzales Zamora
    ;
    David R. Soriano‐Moreno
    ;
    Anderson N. Soriano-Moreno  
    ;
    Linda Ponce-Rosas
    ;
    Lucero Sangster-Carrasco
    Introduction: Due to the high incidence of mpox in Peru and the poor knowledge about this disease among healthcare workers in non-endemic countries, it is crucial to determine the knowledge status of Peruvian physicians. Methodology: We conducted an analytical cross-sectional study based on an online survey from August to September 2022. Physicians who had a medical license and lived and practiced medicine in Peru were included. To evaluate the factors associated with a higher level of knowledge, we used crude (cPR) and adjusted (aPR) prevalence ratios with 95% confidence intervals (95% CI) using Poisson regression. Results: We included 463 physicians. The mean age was 36.6 (SD: 10.3) years, and most were male (58.1%). Regarding knowledge, the median knowledge score was 14 [IQR: 13 to 15] out of 17 points. In terms of knowledge gaps, only 60.7% of the participants knew that there was an FDA-approved vaccine for mpox, 49.0% of participants knew about mpox proctitis and 33.3% acknowledged that it could be transmitted by the bite of an infected rodent. We found that taking care of patients with mpox (aPR: 1.39; 95% CI: 1.13 to 1.72) was associated with higher knowledge (>p50), while living in the eastern macro-region (aPR: 0.62; 95% CI: 0.42 to 0.93) was associated with lower knowledge (≤p50). Conclusions: Our study showed a high level of knowledge about mpox among Peruvian physicians. However, educational campaigns may be necessary, especially for physicians from the eastern region and those who do not have clinical experience with mpox.
    Citas (OpenAlex): 24
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
    Características clínicas y factores asociados a mortalidad en pacientes adultos hospitalizados por COVID-19 en un hospital público de Lima, Perú.
    (2020-06-29)
    Fernando Mejía
    ;
    Carlos Medina
    ;
    Enrique Cornejo Cisneros
    ;
    Enrique Morello
    ;
    Sergio Vásquez
    The COVID-19 pandemic has deeply affected the national health system in Peru, and despite the many strategies implemented to control the epidemic, the collapse of the sanitary system was imminent. We performed a retrospective cohort from the clinical records of adult patients with COVID-19 admitted in Hospital Cayetano Heredia (Lima, Peru), between March and June 2020. A total of 369 patient charts were included for analysis; 241 (65.31%) were male and the median age was 59 years (IQR: 49-68). Most patients (68.56%) reported at least one comorbidity; more frequently: obesity (42.55%), diabetes mellitus (21.95%), and hypertension (21.68%). The median duration of symptoms prior to hospital admission was 7 days (IQR: 5-10). Reported in-hospital mortality was 49.59%. By multiple Cox regression, oxygen saturation (SaO2) level at admission was the main predictor of patient mortality, with SaO2 levels of 84-80% and <80% had 4.44 (95%CI 2.46-8.02) and 7.74 (95%CI 4.54-13.19) times greater risk of death, respectively, when compared to patients with SaO2 >90%. Additionally, older age (>60 years old) was associated with 1.9 times greater mortality. Our study finds SaO2 at admission and older age to be independent predictors of in-hospital mortality. These findings suggest a delay in early detection of hypoxemia in the community, therefore, we propose the implementation of monitoring for hypoxemia among outpatients with COVID-19 as well as appropriate and timely oxygen therapy in admission.
    Citas (OpenAlex): 39
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
    Citas (OpenAlex): 0metric-badges.view 1
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
    Opsoclonus-Myoclonus Syndrome Possibly Associated With Mumps Infection
    (2022-10-01)
    Ana Laura Salazar
    ;
    Takaaki Kobayashi
    ;
    Andrea S. Salcedo
    ;
    Xossé Carreras
    ;
    Jorge Salinas
    Opsoclonus-myoclonus syndrome (OMS) is an infrequent yet serious neurologic entity related to neoplastic, infectious, toxic, and metabolic diseases. In recent years, OMS associated with multiple infections have been reported. In contrast to neoplastic and autoimmune etiologies, OMS from infectious diseases occurs in younger patients and has a favorable outcome. Though the data are limited, the use of corticosteroids and immunotherapy remain the treatments of choice for the management of OMS symptoms. We present a patient case of OMS possibility associated with mumps virus in an immunocompetent young adult who was successfully treated with steroids.
    Citas (OpenAlex): 0metric-badges.view 1
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
    Adherencia a los cuidados paliativos oncologicos del programa Atencion Domiciliaria Integral (ADI) del Hospital Cayetano Heredia
    (2021-05-11)
    Jorge Alave  
    ;
    Karol Herbert Villegas Cayllahua
    En el presente estudio tiene como objetivo evaluar la adherencia terapeutica a traves de la tasa de retencion y factores relacionados con el cuidado de pacientes oncologicos atendidos en el programa Atencion Domiciliaria Integras (ADI) del Hospital Cayetano Heredia. Realizaremos un estudio descriptivo, retrospectivo, revisando las historias clinicas de los pacientes con enfermedad oncologica que se atiende en ADI en los ultimos 6 meses. La medicion de la retencion en el cuidado clinico de estos pacientes sera efectuada utilizando 2 medidas como “adherencia a la cita” y “constancia de la visita”. Este estudio es relevante debido que la OMS manifesto en el 2001 que “la adherencia deficiente al tratamiento de las enfermedades cronicas es un problema mundial de alarmante magnitud”. En el caso de un tratamiento cronico esta estrechamente relacionada con la «retencion del paciente en el sistema de salud» o con lo que es lo mismo, la perdida del seguimiento del paciente. Este tema se ha estudiado especialmente en el tratamiento antirretroviral, porque es obvio que solo tenemos datos de aquellos pacientes que conocemos y seguimos, pero no de los que abandonan el tratamiento. En el Peru hay varios estudios que han investigado la adherencia en pacientes con VIH, tuberculosis, anemia; pero no hay un trabajo que valore la tasa de retencion y factores relacionados en el cuidado de los pacientes oncologicos, siendo frecuente este problema.
    Citas (OpenAlex): 0metric-badges.view 1
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
    Percepciones e intención de los padres de vacunar a sus hijos bajo 12 años de edad contra la COVID-19: estudio transversal en Perú
    (2022-06-01)
    Jose Armando Gonzales Zamora
    ;
    David R. Soriano‐Moreno
    ;
    Anderson N. Soriano-Moreno  
    ;
    Linda Ponce-Rosas
    ;
    Abraham De-Los-Ríos-Pinto
    BACKGROUND: Despite the proven efficacy and safety of COVID-19 vaccines, pediatric vaccination coverage remains low in many countries. There are still doubts and fears in parents about vaccination in their children under 12 years of age. AIM: To evaluate the perceptions and intention of parents to vaccinate their children under 12 years of age. METHODS: Analytical cross-sectional study based on an online survey that evaluated the parents' perceptions regarding the risk of COVID-19 infection, the need for a vaccine, and the vaccine adverse events in their children under 12 years. We assessed the factors associated with the intention to vaccinate through crude (cPR) and adjusted prevalence rates (aPR), with confidence interval of 95% (CI 95%). RESULTS: 83.5% of respondents had the intention to vaccinate their children under 12 years of age. In the multivariate analysis, the factors associated with a decrease in the intention to vaccinate were to believe that the vaccine was not necessary (aPR 0.65; 95% CI 0.44 - 0.94), that it would not protect (aPR: 0.14; 95% CI 0.03 - 0.63), it would not be safe (aPR: 0.80; 95% CI 0.70 - 0.92) and it would cause long-term side effects (aPR: 0.92; 95% CI 0.85 - 1.00). On the other hand, living on the highlands or jungle was associated with an increase in the intention. CONCLUSION: In Peru, 16.5% of parents would not vaccinate their children under 12 years of age, because they perceived that the vaccine was not necessary and would not protect against COVID-19. In addition, they expressed concerns about the development of possible adverse events.
    Citas (OpenAlex): 3metric-badges.view 1
  • Publicacion
    Algunas métricas están bloqueadas por su 
    configuración de consentimiento
    Item type:Publicación,
    8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19-22 July 2015, Vancouver, Canada
    (2015-07-01)
    Pate, KM  
    ;
    Pohlmeyer, C
    ;
    Walker-Sperling, V
    ;
    Foote, J
    ;
    Najarro, K
    Author(s): Pate, Kelly Metcalf; Pohlmeyer, Chris; Walker‐Sperling, Victoria; Foote, Jeremy; Najarro, Kevin; Cryer, Catherine; Salgado, Maria; Gama, Lucio; Engle, Elizabeth; Shirk, Erin; Queen, Suzanne; Chioma, Stanley; Vermillion, Meghan; Bullock, Brandon; Li, Ming; Lyons, Claire; Adams, Robert; Zink, Chris; Clements, Janice; Mankowski, Joseph; Blankson, Joel; Micci, Luca; Ryan, Emily; Fromentin, Rémi; Benne, Clarisse; Chomont, Nicolas; Lifson, Jeffrey; Paiardini, Mirko; Lee, Sulggi; Chomont, Nicolas; Fromentin, Remi; Silicano, Robert; Silicano, Janet; Richman, Douglas; O'Doherty, Una; Palmer, Sarah; Burbelo, Peter; Deeks, Steven; Ghneim, Khader; Ahlers, Jeff; Fourati, Slim; Shive, Carey; Cameron, Mark; Mukerjee, Pranab; Ghannoum, Mahmoud; Rodriguez, Benigno; Deeks, Steven; Lederman, Michael; Sekaly, Rafick; Frange, Pierre; Faye, Albert; Avettand‐Fenoel, Veronique; Bellaton, Erainna; Deschamps, Diane; Angin, Mathieu; Caillat‐Zucman, Sophie; Peytavin, Gilles; Le Chenadec, Jerome; Warszawski, Josiane; Rouzioux, Christine; Saez‐Cirion, Asier; Cohort, ANRS Epf‐Co10 Pediatric; Chang, Christina; Cameron, Paul; Elliott, Julian; Perelson, Alan; Roche, Michael; Dantanarayana, Ashanti; Solomon, Ajantha; Naranbhai, Vivek; Tenakoon, Surekha; Hoh, Rebecca; McMahon, James; Sikaris, Ken; Hartogensis, Wendy; Bacchetti, Peter; Hecht, Frederick; Lifson, Jeffrey; Deeks, Steve; Lewin, Sharon; Byrareddy, Siddappa; Arthos, James; Cicala, Claudia; Reimann, Keith; Parslow, Tristram
    Citas (OpenAlex): 16